Cargando…

Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron

Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Rui, Hu, Taojun, Zhang, Yunjun, Li, Yang, Zhou, Xiao-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026126/
https://www.ncbi.nlm.nih.gov/pubmed/35455246
http://dx.doi.org/10.3390/vaccines10040496
_version_ 1784691047840874496
author Dong, Rui
Hu, Taojun
Zhang, Yunjun
Li, Yang
Zhou, Xiao-Hua
author_facet Dong, Rui
Hu, Taojun
Zhang, Yunjun
Li, Yang
Zhou, Xiao-Hua
author_sort Dong, Rui
collection PubMed
description Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are appropriate and reasonable. Based on both virus genomes and daily-confirmed cases, we compare the additive differences in growth rates and reproductive numbers ([Formula: see text]) between VOCs and their predominant variants through a Bayesian framework and phylo-dynamics analysis. Faced with different variants, we evaluate the effects of current policies and vaccinations against VOCs and predominant variants. The model also predicts the date on which a VOC may become dominant based on simulation and real data in the early stage. The results suggest that the overall additive difference in growth rates of B.1.617.2 and predominant variants was 0.44 (95% confidence interval, 95% CI: −0.38, 1.25) in February 2021, and that the VOC had a relatively high [Formula: see text]. The additive difference in the growth rate of BA.1 in the United Kingdom was 6.82 times the difference between Delta and Alpha, and the model successfully predicted the dominating process of Alpha, Delta and Omicron. Current vaccination strategies remain similarly effective against Delta compared to the previous variants. Our model proposes a reliable Bayesian framework to predict the spread trends of VOCs based on early-stage data, and evaluates the effects of public health policies, which may help us better prepare for the upcoming Omicron variant, which is now spreading at an unprecedented speed.
format Online
Article
Text
id pubmed-9026126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90261262022-04-23 Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron Dong, Rui Hu, Taojun Zhang, Yunjun Li, Yang Zhou, Xiao-Hua Vaccines (Basel) Article Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are appropriate and reasonable. Based on both virus genomes and daily-confirmed cases, we compare the additive differences in growth rates and reproductive numbers ([Formula: see text]) between VOCs and their predominant variants through a Bayesian framework and phylo-dynamics analysis. Faced with different variants, we evaluate the effects of current policies and vaccinations against VOCs and predominant variants. The model also predicts the date on which a VOC may become dominant based on simulation and real data in the early stage. The results suggest that the overall additive difference in growth rates of B.1.617.2 and predominant variants was 0.44 (95% confidence interval, 95% CI: −0.38, 1.25) in February 2021, and that the VOC had a relatively high [Formula: see text]. The additive difference in the growth rate of BA.1 in the United Kingdom was 6.82 times the difference between Delta and Alpha, and the model successfully predicted the dominating process of Alpha, Delta and Omicron. Current vaccination strategies remain similarly effective against Delta compared to the previous variants. Our model proposes a reliable Bayesian framework to predict the spread trends of VOCs based on early-stage data, and evaluates the effects of public health policies, which may help us better prepare for the upcoming Omicron variant, which is now spreading at an unprecedented speed. MDPI 2022-03-24 /pmc/articles/PMC9026126/ /pubmed/35455246 http://dx.doi.org/10.3390/vaccines10040496 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dong, Rui
Hu, Taojun
Zhang, Yunjun
Li, Yang
Zhou, Xiao-Hua
Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title_full Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title_fullStr Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title_full_unstemmed Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title_short Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron
title_sort assessing the transmissibility of the new sars-cov-2 variants: from delta to omicron
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026126/
https://www.ncbi.nlm.nih.gov/pubmed/35455246
http://dx.doi.org/10.3390/vaccines10040496
work_keys_str_mv AT dongrui assessingthetransmissibilityofthenewsarscov2variantsfromdeltatoomicron
AT hutaojun assessingthetransmissibilityofthenewsarscov2variantsfromdeltatoomicron
AT zhangyunjun assessingthetransmissibilityofthenewsarscov2variantsfromdeltatoomicron
AT liyang assessingthetransmissibilityofthenewsarscov2variantsfromdeltatoomicron
AT zhouxiaohua assessingthetransmissibilityofthenewsarscov2variantsfromdeltatoomicron